Centenial Surgical Suture Complete Financial Statements
In FY2026, Centenial Surgical Suture (CSURGSU) reported revenue ₹54 Cr, net profit ₹-2 Cr and EPS ₹-6.04, with a net profit margin of -3.7% and ROE of -6.9%. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Also explore Centenial Surgical Suture stock price data download to track price trends across different timeframes.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
CSURGSU Revenue, Net Profit & EBITDA — Year-on-Year Growth
CSURGSU YoY (March 2025 vs March 2026), EBITDA -16.7%, expenses +4.3%. Analyse CSURGSU shareholder distribution to track promoter, FII and institutional holdings.
CSURGSU Income Statement — Revenue, EBITDA & Net Profit
Centenial Surgical Suture revenue ₹54 Cr, EBITDA ₹5 Cr, net profit ₹-2 Cr, EPS ₹-6.04 (2026) — net profit margin -3.7%. For live price, earnings ratios and company overview, see CSURGSU share price screener.
| Particulars | March 2026 | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 54 | 54 | 51 | 53 | 45 | 37 | 56 | 56 | 53 | 53 | 52 | 52 |
| Expenses | 49 | 47 | 46 | 48 | 40 | 32 | 50 | 51 | 48 | 48 | 47 | 47 |
| EBITDA | 5 | 6 | 5 | 4 | 5 | 5 | 6 | 5 | 5 | 5 | 5 | 5 |
| Operating Profit Margin % | 9.00% | 12.00% | 10.00% | 8.00% | 10.00% | 14.00% | 10.00% | 9.00% | 8.00% | 9.00% | 9.00% | 10.00% |
| Depreciation | 4 | 4 | 1 | 1 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
| Interest | 3 | 4 | 3 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 2 |
| Profit Before Tax | -2 | -2 | 1 | 2 | 1 | 2 | 2 | 3 | 2 | 3 | 2 | 3 |
| Tax | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Net Profit | -2 | -2 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 |
| Earnings Per Share (₹) | -6.04 | -4.01 | 3.11 | 2.43 | 1.72 | 2.64 | 3.55 | 5.53 | 4.23 | 4.71 | 4.28 | 5.25 |
CSURGSU Balance Sheet — Assets, Liabilities & Shareholders' Equity
CSURGSU total assets ₹80 Cr, total equity ₹29 Cr, total liabilities ₹ Cr (2026) — ROE -6.9%.
| Particulars | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| Total Assets | 80 | 85 | 79 | 66 | 61 | 70 | 69 | 57 | 55 | 56 | 53 | 55 |
| Current Assets | 60 | 63 | 65 | 59 | 53 | 61 | 58 | 52 | 51 | 52 | 49 | 51 |
| Fixed Assets | 18 | 20 | 13 | 7 | 8 | 9 | 10 | 4 | 4 | 4 | 4 | 4 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 41 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 0 | 65 | 66 | 60 | 54 | 61 | 59 | 53 | 51 | 52 | 49 | 51 |
| LIABILITIES | ||||||||||||
| Total Liabilities | ||||||||||||
| Current Liabilities | 20 | 22 | 14 | 6 | 7 | 9 | 10 | 3 | 3 | 3 | 3 | 3 |
| Non-Current Liabilities | ||||||||||||
| SHAREHOLDERS' EQUITY | ||||||||||||
| Total Equity | 29 | 31 | 32 | 31 | 30 | 30 | 29 | 28 | 26 | 25 | 23 | 21 |
| Share Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves & Surplus | 23 | 25 | 27 | 26 | 25 | 24 | 23 | 23 | 21 | 19 | 17 | 16 |
CSURGSU Cash Flow Statement — Operating, Investing & Financing
Centenial Surgical Suture operating cash flow ₹17 Cr, investing ₹-12 Cr, financing ₹-6 Cr, net cash flow ₹-1 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 17 | 6 | 1 | 5 | 2 | 2 | 2 | 2 | 0 | -2 | 0 |
| Investing Activities | -12 | -8 | 0 | 0 | -1 | -1 | -1 | -1 | -2 | 0 | 0 |
| Financing Activities | -6 | 2 | -1 | -5 | -1 | 0 | -1 | -1 | 2 | 1 | 1 |
| Net Cash Flow | -1 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 | -1 | 1 |